Reid O'Brien Johnson

Title: Reid O'Brien Johnson: Innovator in Protein Measurement Technologies

Introduction

Reid O'Brien Johnson is a notable inventor based in Hartsdale, NY (US). He has made significant contributions to the field of protein measurement, particularly in the area of post-translational modifications. His innovative approach has the potential to enhance the accuracy of protein quantification, which is crucial in various biotechnological applications.

Latest Patents

Johnson holds a patent titled "Heavy peptide approach to accurately measure unprocessed C-terminal lysine." This patent provides a method for accurately measuring post-translational modifications in proteins, such as antibodies. The method utilizes heavy isotopic standards to generate a calibration curve, allowing for precise quantitation of modified peptides. This technique is particularly useful for quantifying C-terminal truncation in antibodies using mass spectrometry.

Career Highlights

Reid O'Brien Johnson is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in protein measurement technologies. His work contributes to the advancement of therapeutic antibody development and other biopharmaceutical innovations. Johnson's dedication to research and development has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Johnson collaborates with esteemed colleagues, including Milos Cejkov and Xiaojing Zheng. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Reid O'Brien Johnson's contributions to protein measurement technologies exemplify the impact of innovative thinking in biotechnology. His patent and work at Regeneron Pharmaceuticals, Inc. highlight the importance of accurate protein quantification in advancing medical research and therapeutic development.